UNSPSC 51131625: Bivalirudin

This classification denotes an anticoagulant agent with the molecular formula C98H138N24O33, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TN9BEX005G, chemically known as l-leucine, d-phenylalanyl-l-prolyl-l-arginyl-l-prolylglycylglycylglycylglycyl-l-asparaginylglycyl-l-alpha-aspartyl-l-phenylalanyl-l-alpha-glutamyl-l-alpha-glutamyl-l-isoleucyl-l-prolyl-l-alpha-glutamyl-l-alpha-glutamyl-l-tyrosyl- but generally known as bivalirudin, which bears US NIH Compound Identifier 16129704.

UNSPSC 51131625 Bivalirudin is a Commodity code that appears in state and local procurement records with minimal recent activity directly aligned to its nominal scope. The single recent opportunity tagged to this code—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—solicits law enforcement equipment on behalf of a multistate cooperative purchasing vehicle, not pharmaceutical products or anticoagulant agents. The mismatch between the code's pharmaceutical definition and the actual solicitation scope signals either a tagging error in the state or local procurement system or a data classification issue rather than genuine market demand for bivalirudin through state and local government channels.

The law enforcement equipment opportunity itself represents activity through Sourcewell, a Minnesota local government unit and service cooperative that aggregates demand across Franklin, Grant, Grays Harbor, Chelan, and Yakima counties in Washington, plus numerous other public entities nationwide and in Canada. The resulting contract framework is intended for use by thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, tribal governments, and other public sector bodies. However, because this solicitation bears no clear relationship to bivalirudin procurement, it does not constitute actionable market intelligence for vendors in the pharmaceutical or medical device space. State and local procurement of bivalirudin through direct commodity codes appears dormant in the available records as of mid-2026.